It is estimated that more than 177,000 older adults are hospitalized and 14,000 of them die in the US due to RSV infections per year. In 2018, more elder Americans died from RSV infection than the common flu.
AMR locations nationwide are currently enrolling in investigational Adult RSV vaccine clinical research studies. Respiratory Syncytial Virus – or RSV – is most commonly discussed in children ages newborn to four. However, RSV, much like the flu or coronavirus, can cause long-term damage to the lungs. It can be life-threatening for adults 60 years and older and for those with compromised health conditions.
To learn more, call our enrollment line: